Regentatlantic Capital LLC lowered its stake in shares of Aetna Inc (NYSE:AET) by 8.9% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 86,901 shares of the company’s stock after selling 8,444 shares during the quarter. Aetna accounts for about 1.3% of Regentatlantic Capital LLC’s portfolio, making the stock its 11th largest position. Regentatlantic Capital LLC’s holdings in Aetna were worth $15,676,000 as of its most recent filing with the Securities and Exchange Commission.
Several other institutional investors also recently bought and sold shares of the company. Lloyds Banking Group plc purchased a new position in Aetna in the third quarter valued at $106,000. Moisand Fitzgerald Tamayo LLC purchased a new position in Aetna in the third quarter valued at $116,000. Westside Investment Management Inc. increased its holdings in Aetna by 53.5% in the second quarter. Westside Investment Management Inc. now owns 1,148 shares of the company’s stock valued at $177,000 after buying an additional 400 shares during the last quarter. Phocas Financial Corp. purchased a new position in Aetna in the second quarter valued at $182,000. Finally, Highstreet Asset Management Inc. increased its holdings in Aetna by 105.5% in the third quarter. Highstreet Asset Management Inc. now owns 1,243 shares of the company’s stock valued at $198,000 after buying an additional 638 shares during the last quarter. 87.10% of the stock is currently owned by institutional investors and hedge funds.
AET has been the topic of several recent analyst reports. ValuEngine raised Aetna from a “hold” rating to a “buy” rating in a report on Sunday, December 31st. Piper Jaffray Companies raised Aetna from a “neutral” rating to an “overweight” rating and set a $136.00 target price on the stock in a report on Wednesday, January 3rd. Argus lowered Aetna from a “buy” rating to a “hold” rating and set a $185.00 target price on the stock. in a report on Wednesday, December 6th. Morgan Stanley lowered Aetna from an “overweight” rating to an “equal weight” rating and set a $179.00 target price on the stock. in a report on Wednesday, December 20th. Finally, Jefferies Group increased their target price on Aetna from $165.00 to $185.00 and gave the company a “hold” rating in a report on Wednesday, November 1st. Ten analysts have rated the stock with a hold rating and fourteen have assigned a buy rating to the company’s stock. Aetna has an average rating of “Buy” and a consensus price target of $185.94.
Aetna Inc (AET) traded down $1.75 during midday trading on Wednesday, reaching $176.77. 1,912,793 shares of the company’s stock traded hands, compared to its average volume of 2,980,000. Aetna Inc has a one year low of $121.60 and a one year high of $194.40. The firm has a market capitalization of $57,790.00, a P/E ratio of 30.74, a PEG ratio of 1.44 and a beta of 0.60. The company has a quick ratio of 0.53, a current ratio of 1.68 and a debt-to-equity ratio of 0.52.
Aetna (NYSE:AET) last announced its earnings results on Tuesday, January 30th. The company reported $1.25 earnings per share for the quarter, topping the consensus estimate of $1.18 by $0.07. Aetna had a net margin of 3.15% and a return on equity of 21.50%. The business had revenue of $14.74 billion during the quarter, compared to the consensus estimate of $14.79 billion. During the same quarter in the prior year, the firm earned $0.08 earnings per share. The business’s quarterly revenue was down 6.2% compared to the same quarter last year. sell-side analysts anticipate that Aetna Inc will post 10.99 earnings per share for the current year.
The firm also recently announced a quarterly dividend, which was paid on Friday, January 26th. Stockholders of record on Thursday, January 11th were paid a dividend of $0.50 per share. The ex-dividend date was Wednesday, January 10th. This represents a $2.00 annualized dividend and a dividend yield of 1.13%. Aetna’s dividend payout ratio (DPR) is 34.78%.
TRADEMARK VIOLATION WARNING: This report was originally reported by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are accessing this report on another website, it was copied illegally and republished in violation of United States & international trademark & copyright legislation. The original version of this report can be viewed at https://www.dispatchtribunal.com/2018/02/15/regentatlantic-capital-llc-sells-8444-shares-of-aetna-inc-aet.html.
Aetna Company Profile
Aetna Inc is a diversified healthcare benefits company. The Company operates through three segments: Health Care, Group Insurance and Large Case Pensions. It offers a range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental, behavioral health, group life and disability plans, medical management capabilities, Medicaid healthcare management services, Medicare Advantage and Medicare Supplement plans, workers’ compensation administrative services and health information technology (HIT) products and services.
Receive News & Ratings for Aetna Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aetna and related companies with MarketBeat.com's FREE daily email newsletter.